IBM sells off large parts of Watson Health business
pharmaphorum
JANUARY 24, 2022
IBM said the sell-off is tagged as “a clear next step” as it focuses on its platform-based hybrid cloud and artificial intelligence strategy, but it’s no secret that Watson Health has failed to live up to its early promise. IBM’s step back from health comes as tech rivals are still piling into the sector.
110 
Let's personalize your content